San Antonio, TX, December 9, 2025
The San Antonio Breast Cancer Symposium (SABCS) will be held at the Henry B. González Convention Center, featuring innovative research from the Icahn School of Medicine. This event fosters collaboration among global experts and supports advancements in breast cancer treatment, highlighting the importance of community involvement in medical progress.
San Antonio, TX – The 2025 San Antonio Breast Cancer Symposium (SABCS) is set to take place from December 9 to 12 at the Henry B. González Convention Center, showcasing groundbreaking research from the Icahn School of Medicine at Mount Sinai. This prestigious event is a pivotal gathering of leading experts in breast cancer research and treatment, fostering collaboration and innovation in the field.
SABCS has become a cornerstone for advancing breast cancer knowledge and improving patient outcomes. The symposium attracts over 10,000 participants from around the globe, emphasizing San Antonio’s role as a hub for medical advancements. Local organizers deserve commendation for their efforts in hosting this vital event, which highlights the benefits of community involvement and partnerships in steering medical progress forward.
Mount Sinai’s Contributions to SABCS 2025
Researchers from Mount Sinai are presenting a range of studies that illustrate the integration of cutting-edge technology and diverse patient data in the fight against breast cancer. One of the key presentations will be by Dr. Joseph Sparano, focusing on multimodal artificial intelligence models that predict breast cancer recurrence. This innovative approach, utilizing a combination of imaging, clinical, and molecular data, represents a significant stride toward personalized patient care.
Innovative Approaches to Treatment
At the symposium, several poster presentations will cover novel therapeutic strategies for different breast cancer subtypes, particularly triple-negative breast cancer, which is challenging to treat. Dr. Hanna Irie will share advancements in targeting brain metastases, while Dr. Justine M. Anderson will discuss the tolerability of the KEYNOTE-522 regimen in a diverse cohort of patients. These studies are critical as they address variations in treatment responses among different demographics.
Geriatric Assessments in Oncology
The aging population presents unique challenges in oncology, prompting research into tailored interventions. Dr. Rima Patel is set to present on the safety and efficacy of new treatment combinations for older adults with early triple-negative breast cancer. Additionally, her work highlighting the feasibility of clinical nurse-initiated geriatric assessments in breast medical oncology clinics underscores a proactive approach to improving care for elderly patients.
A Comprehensive Scientific Program
This year’s SABCS will offer a robust scientific program that encompasses plenary lectures, oral sessions, and workshops, facilitating a rich exchange of knowledge among local and international professionals. Such gatherings not only advance scientific understanding but also promote collaboration among researchers and practitioners, vital for the continued evolution of breast cancer treatment.
The Importance of Local Engagement
The ongoing efforts to combat breast cancer are strengthened by local leadership and the engagement of private partnerships. Events like the SABCS showcase how a vibrant community can come together to provide support and create opportunities for innovation in medical research. This collective effort is crucial for transforming scientific advancements into real-world applications that can improve patient outcomes in San Antonio and beyond.
Conclusion
The San Antonio Breast Cancer Symposium 2025 promises to be a landmark event for breast cancer research and treatment. With a focus on collaboration, innovation, and patient-centered care, the symposium exemplifies the power of local efforts in tackling significant health challenges. As the event draws near, community members are encouraged to engage with these advancements and support ongoing initiatives aimed at improving cancer care.
Frequently Asked Questions
What is the San Antonio Breast Cancer Symposium (SABCS)?
The San Antonio Breast Cancer Symposium is a leading conference dedicated to breast cancer research and clinical advances, bringing together global experts to highlight the latest insights shaping future care.
When and where is the 2025 SABCS being held?
The 2025 SABCS is scheduled for December 9-12, 2025, at the Henry B. González Convention Center in San Antonio, Texas.
What are some of Mount Sinai’s presentations at SABCS 2025?
Mount Sinai’s presentations include topics such as multimodal artificial intelligence models for predicting breast cancer recurrence, novel therapeutic approaches for triple-negative breast cancer brain metastases, and the tolerability of the KEYNOTE-522 regimen in diverse patient cohorts.
How many attendees are expected at SABCS 2025?
Over 10,000 attendees from more than 100 countries are expected at the 2025 SABCS.
What is the Icahn School of Medicine at Mount Sinai?
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals of the Mount Sinai Health System, providing care to New York City’s large and diverse patient population.
| Presentation Title | Presenter | Session Type | Date and Time |
|---|---|---|---|
| Multimodal Artificial Intelligence Models for Predicting Breast Cancer Recurrence in TAILORx | Dr. Joseph Sparano | Oral Session | Wednesday, December 10, 9:30 am – noon CST |
| Novel Therapeutic Targeting Triple-Negative Breast Cancer Brain Metastases | Dr. Hanna Irie | Poster Session | To be announced |
| Tolerability of the KEYNOTE-522 Regimen in a Diverse Real-World Cohort | Dr. Justine M. Anderson | Poster Session | To be announced |
| Evaluating Real-World Pathologic Complete Response Rates Following the KEYNOTE-522 Regimen | Dr. Justine M. Anderson | Poster Session | To be announced |
| Tolerability of Adjuvant Pembrolizumab and Capecitabine Combination | Dr. Prathyusha Pandu | Poster Session | To be announced |
| Safety and Efficacy of Neoadjuvant Cyclophosphamide, Methotrexate, Fluorouracil (CMF), and Pembrolizumab in Older Adults with Early Triple-Negative Breast Cancer | Dr. Rima Patel | Presentation | To be announced |
| Feasibility of Clinical Nurse-Initiated Geriatric Assessments in Breast Medical Oncology Clinic: A Pilot Program | Dr. Rima Patel | Presentation | To be announced |
Deeper Dive: News & Info About This Topic
HERE Resources
Intensity Therapeutics Presenting at San Antonio Breast Cancer Symposium
Plus Therapeutics to Present Groundbreaking Research at SABCS
Plus Therapeutics to Present Breakthrough Study on Cancer Treatment
Classic Collision Acquires Fawbush Body Shop in Livingston
ESMO 2025 Announces Key Events and Speakers
San Antonio Set to Welcome New Multispecialty and Research Hospital
San Antonio University Tackles Rising Cancer Rates in Latino Community
Author: STAFF HERE SAN ANTONIO WRITER
The SAN ANTONIO STAFF WRITER represents the experienced team at HERESanAntonio.com, your go-to source for actionable local news and information in San Antonio, Bexar County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Fiesta San Antonio, San Antonio Stock Show & Rodeo, and Dia de los Muertos. Our coverage extends to key organizations like the Greater San Antonio Chamber of Commerce and United Way of San Antonio and Bexar County, plus leading businesses in retail, insurance, and energy that power the local economy such as H-E-B, USAA, and Valero Energy. As part of the broader HERE network, including HEREAustinTX.com, HERECollegeStation.com, HEREDallas.com, and HEREHouston.com, we provide comprehensive, credible insights into Texas's dynamic landscape.
